Drug Information and Pharmacotherapy

DI-014

DOES BOTULINUM TOXIN SURGERY CHANGE QUALITY OF LIFE IN AXILLARY HYPERHIDROSIS? WHAT PATIENTS THINK

DI-062

ROMIPLOSTIM AND ELTROMBOPAG IN THE TREATMENT OF IDIOPATIC THROMBOCYTOPENIC PURPURA

DI-084

ACENOCOUMAROL DRUG INTERACTIONS IN HOSPITALISED PATIENTS

DI-099

EFFECTIVENESS AND SAFETY STUDY IN CHILDREN WITH STEROID-DEPENDENT NEPHROTIC SYNDROME TREATED WITH LEVAMISOLE

DI-064

BOTULINUM TOXIN TYPE A: EXPERIENCE WITH 51 PATIENTS OF A NEUROLOGY DEPARTMENT

DI-106

A PROTOCOL FOR THE SELECTION OF ANALGESIC MIXTURE DRUGS ACCORDING TO PAIN INTENSITY IN A POSTOPERATIVE PAIN UNIT

DI-105

EPIDEMIOLOGICAL MONITORING OF ADVERSE DRUG REACTIONS IN PAEDIATRIC EMERGENCY DEPARTMENTS

DI-104

TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA: USE AND SAFETY PROFILE

DI-103

A TOOL FOR SHARING KNOWLEDGE - THE HOSPITAL PHARMACIES INFORMATION DATABASES REGARDING MEDICINES

DI-097

BUDESONIDE SUSPENSION FOR EOSINOPHILIC ESOPHAGITIS

DI-096

ADALIMUMAB FOR THE TREATMENT OF BEHCET’S DISEASE

DI-087

DRUG USE EVALUATION: EFFECTIVENESS, SAFETY AND COST OF EMTRICITABINE/TENOFOVIR/RILPIVIRINE

DI-086

REVIEW OF OFF-LABEL USE AND ECONOMIC IMPACT OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN A TERTIARY HOSPITAL

DI-085

ADVERSE REACTIONS TO RADIOPHARMACEUTICALS: LITERATURE REVIEW OF THE PAST 70 YEARS

DI-083

DEPRESCRIBING STRATEGIES IN ELDERLY PATIENTS OR PATIENTS WITH SEVERAL CHRONIC CONDITIONS

Pages